SCHEMBL20122367

SCHEMBL20122367

CC(C)(S)C(=O)N[C@@H](CSC(=O)OCOC(=O)c1ccccc1)C(=O)OC1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ SCN1A P35498 1/20 0.38
▸ SCN2A Q99250 1/20 0.38
▸ SCN3A Q9NY46 1/20 0.38
▸ ACE P12821 2/20 0.36
▸ MME P08473 1/20 0.36
▸ ACE2 Q9BYF1 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ MMP2 P08253 2/20 0.34
▸ MMP9 P14780 2/20 0.34
▸ ANPEP P15144 2/20 0.34
▸ LTA4H P09960 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122395 0.90 LMNA (0.37) SMN1; SMN2LMNARAB9ACYP1A2CYP2D6
SCHEMBL20122368 0.85 ACE (0.42) LMNACYP2D6SCN1ASCN2ASCN3A
SCHEMBL20122572 0.85 EPHX1 (0.31) CACNA1B
SCHEMBL20122588 0.84 ACE (0.48) LMNACYP2D6SCN1ASCN2ASCN3A
SCHEMBL20122366 0.84 ACE (0.41) CYP2D6SCN1ASCN2ASCN3AACE
SCHEMBL20122374 0.84 CYP19A1 (0.31) —
SCHEMBL20122369 0.84 ACE (0.41) SMN1; SMN2LMNARAB9ACYP2D6NPC1
SCHEMBL20122365 0.83 ACE (0.40) SMN1; SMN2LMNARAB9ACYP2D6NPC1
SCHEMBL20122476 0.83 ACE (0.40) LMNACYP2D6SCN1ASCN2ASCN3A
SCHEMBL20122478 0.82 KMT2A (0.43) SMN1; SMN2LMNARAB9ACYP2D6SCN1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback